Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06995924

Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education

This pilot clinical trial looks at whether patient navigation services, an interactive web education intervention, called Current Together After Cancer (CTAC), or both navigation and CTAC works to improve the uptake of surveillance in patients with stage I-III colorectal cancer (CRC). Post-treatment surveillance is critical to detect recurrence early, yet many CRC survivors do not receive recommended surveillance care. Surveillance is a complex process that includes laboratory tests, cross-sectional imaging, and endoscopic procedures. Patient navigation services, interactive web education, or a combination of both may improve surveillance care for patients with stage I-III colorectal cancer.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States

Loading trial locations.

About this study

OUTLINE:

Patients are assigned to 1 of 3 arms based on the clinic location they receive cancer care at.

ARM A (VIRGINIA MASON): Patients receive access to navigation services, including education on surveillance care, reminders to complete care and assistance in scheduling surveillance, within 3 months of standard of care surgical resection for stage I-III CRC.

ARM B (FRED HUTCH [SOUTH LAKE UNION]): Patients receive access to the CTAC intervention, which includes self-directed, interactive web-based education about surveillance and a checklist of care, within 3 months of standard of care surgical resection for stage I-III CRC.

ARM C (FRED HUTCH [OVERLAKE + EVERGREEN]): Patients receive access to navigation services, including education on surveillance care, reminders to complete care and assistance in scheduling surveillance, and access to the CTAC intervention, which includes self-directed, interactive web-based education about surveillance and a checklist of care, within 3 months of standard of care surgical resection for stage I-III CRC.

Patients are followed up at 3 months post study-enrollment and 12-18 months after surgical resection.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 due to disease and clinic population
  • Stage I-III CRC survivor within 3 months post-surgical resection
  • Being seen at a participating clinic
  • Ability to understand and complete surveys in English

Treatment and study plan

Educational Intervention

Other

Complete self-directed interactive education

Other names: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational

Electronic Health Record Review

Other

Ancillary studies

Internet-Based Intervention

Other

Receive access to CTAC

Patient Navigation

Behavioral

Receive patient navigation services

Other names: Patient Navigator Program

Survey Administration

Other

Ancillary studies

Primary outcomes

  1. Completion of colonoscopy (stage I colorectal carcinoma patients)

    Time frame: Up to 18 months post-surgical resection

  2. Completing any colonoscopy, carcinoembryonic antigen tumor marker (CEA), and cross-sectional imaging (stage II-III colorectal carcinoma patients)

    Time frame: Up to 18 months post-surgical resection

    Will compare rates of surveillance care completion 1-year (up to 18 months accounting for delays that may be due to inability accessing endoscopy) post-surgical resection across groups using chi-square tests. Will use a multivariable logistic regression model to test for factors that may be associated with increased or decreased surveillance care including patient-level demographic factors (e.g., age, sex, etc.) and available clinic-level factors (e.g., clinic size, etc.).

Secondary outcomes

  1. Knowledge of colorectal cancer (CRC) surveillance

    Time frame: At baseline, and 3 months post enrollment

    Knowledge will be assessed using a previously validated 5-item scale. Responses will be graded on a scale of 0 to 5 with higher scores representing higher knowledge; scores can also be dichotomized into high and low knowledge.

  2. Self-efficacy to complete CRC surveillance

    Time frame: At baseline, and 3 months post enrollment

    Will be measured using 7-items on a 5-point Likert scale ("strongly disagree" to "strongly agree"). Responses will be averaged with higher scores indicating greater self-efficacy.

  3. Acceptability of the intervention

    Time frame: At 3 months post enrollment

    Assessed using Acceptability of the Intervention Measure. Will calculate and compare mean scores between individual participants and exposure group using student's t-test.

  4. Intervention appropriateness

    Time frame: At 3 months post enrollment

    Assessed using Intervention Appropriateness Measure (IAM). Will calculate and compare mean scores between individual participants and exposure group using student's t-test.

  5. Feasibility of the intervention

    Time frame: At 3 months post enrollment

    Assessed using Feasibility of Intervention Measure (FIM) scores. Will calculate and compare mean scores between individual participants and exposure group using student's t-test.

Study contacts

Contact information is provided by the study sponsor or research team.

Ari Bell-Brown

CONTACT

[email protected]

206.667.7624

Sponsors and collaborators

Lead sponsor

Fred Hutchinson Cancer Center

Other

Registry information

Official study title

A Pilot Trial to Evaluate the Effectiveness of Navigation, Interactive Web Education, or the Combination of Both to Promote Guideline-Concordant Colorectal Cancer Surveillance Care

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
May 30, 2025
Registry last updated
Feb 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.